ArticleDigital health
Prediction of reduced left ventricular ejection fraction using atrial fibrillation or flutter electrocardiograms: A machine-learning study.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Although the evaluation of left ventricular ejection fraction (LVEF) in patients with atrial fibrillation (AF) or atrial flutter (AFL) is crucial for appropriate medical management, the prediction of reduced LVEF (<50%) with AF/AFL electrocardiograms (ECGs) lacks evidence. This study aimed to investigate deep-learning approaches to predict reduced LVEF (<50%) in patients with AF/AFL ECGs and easily obtainable clinical information. Methods: Patients with 12-lead ECGs of AF/AFL and echocardiography were divided into those with LVEF <50% and ≥50%. A convolutional neural networks-based model customized to the study (AFibEFNet) and other deep-learning models were investigated. Electrocardiogram signals, ECG features, and clinical features (demographic information, comorbidities, blood cell counts, and blood test results) were collected for training. A hold-out test dataset was constructed using a different recruitment period. Five-fold cross-validation and calibration plots were used to evaluate performance. Results: A total of 15,683 patients were analyzed (mean age, 70.0 ± 11.7 years; 61.2% men), with 82.2% having LVEF ≥50% and 17.8% having LVEF < 50%. Among the learning models, the AFibEFNet outperformed other models regarding area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), and F1-score. Using ECG signals alone, the AFibEFNet model predicted reduced LVEF with AUROC of 0.798 (95% confidence interval [CI], 0.767-0.829) and AUPRC of 0.508 (95% CI, 0.434-0.564). For the AFibEFNet model, additional training with ECG and clinical features significantly improved AUROC (0.816 vs. 0.798, Conclusions: Among the patients with AF/AFL, machine learning may predict reduced LVEF with 12-lead ECGs of AF/AFL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.